JHS Svendgaard Laboratories Ltd

JHS Sven.Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

JHS Svendgaard Laboratories Ltd

₹ 21.6 1.07%
22 Nov - close price
svendgaard.com BSE: 532771 NSE: JHS
About

Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of
oral and dental products for national and international brands[1]

Key Points

Business Overview:[1]
JHSSLL manufactures Toothbrushes, Toothpastes, Mouthwash and Denture Tablets. Apart from working on its own brands viz. Dr. Gold, Aquawhite, etc. company also offers Contract Manufacturing Partnership to brands in domestic and international markets

Website BSE NSE
  • Market Cap ₹ 170 Cr.
  • Current Price ₹ 21.6
  • High / Low ₹ 39.5 / 15.5
  • Stock P/E
  • Book Value ₹ 23.2
  • Dividend Yield 0.00 %
  • ROCE -1.69 %
  • ROE -2.36 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.94 times its book value
  • Company's working capital requirements have reduced from 112 days to 71.8 days

Cons

  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -3.17%
  • The company has delivered a poor sales growth of -10.6% over past five years.
  • Promoter holding is low: 34.6%
  • Company has a low return on equity of -1.22% over last 3 years.
  • Earnings include an other income of Rs.4.89 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Personal Care - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
25 21 19 21 21 22 22 16 19 14 22 24 20
24 22 19 23 23 24 25 18 19 14 21 23 21
Operating Profit 1 -1 -0 -1 -2 -2 -4 -2 0 -0 1 2 -1
OPM % 5% -5% -1% -7% -9% -10% -16% -13% 2% -0% 4% 8% -4%
2 3 2 1 3 1 -12 0 0 2 1 0 1
Interest 0 0 1 1 0 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 1 1 2 1 2 2 2 2 2
Profit before tax 1 -0 -0 -2 -1 -3 -17 -3 -1 1 0 0 -2
Tax % 34% -92% 7,300% 76% -13% -5% -36% -18% -26% 100% 517% 415% 398%
0 -0 -4 -4 -1 -3 -11 -3 -1 0 -1 -1 -10
EPS in Rs 0.04 0.04 -0.67 -0.59 -0.14 -0.43 -1.65 -0.40 -0.09 0.00 -0.10 -0.08 -1.32
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
60 35 55 100 104 140 124 139 101 86 85 71 80
48 39 59 93 92 126 124 137 99 87 94 72 78
Operating Profit 12 -4 -4 7 12 14 0 2 2 -1 -9 -1 2
OPM % 20% -11% -7% 7% 11% 10% 0% 1% 2% -1% -11% -1% 2%
12 -3 -6 -17 0 32 6 3 7 9 -7 4 5
Interest 10 14 0 0 1 1 1 2 1 1 1 0 0
Depreciation 14 15 12 10 6 7 7 9 7 7 6 6 7
Profit before tax 0 -35 -22 -22 5 38 -2 -6 1 0 -23 -3 -1
Tax % 1,357% -18% 0% 0% -327% 32% -19% -17% -39% 4,000% -24% 18%
-4 -29 -22 -22 22 26 -2 -5 1 -4 -18 -4 -12
EPS in Rs -1.56 -11.95 -9.20 -5.76 4.98 4.29 -0.11 -0.33 0.19 -0.62 0.62 1.97 -1.50
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 7%
5 Years: -11%
3 Years: -11%
TTM: 2%
Compounded Profit Growth
10 Years: 6%
5 Years: %
3 Years: %
TTM: -735%
Stock Price CAGR
10 Years: 11%
5 Years: 6%
3 Years: -2%
1 Year: -16%
Return on Equity
10 Years: 0%
5 Years: 0%
3 Years: -1%
Last Year: -2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 24 24 24 38 44 61 61 61 64 65 78 78 86
Reserves 65 38 96 57 86 113 116 117 124 121 95 91 96
101 54 19 3 2 2 7 9 7 6 3 5 4
41 74 33 25 23 32 39 55 33 30 52 22 22
Total Liabilities 232 190 171 122 155 208 223 241 228 222 228 197 208
135 121 108 65 65 71 71 66 63 59 65 90 90
CWIP 0 0 0 1 1 1 5 7 9 20 9 1 2
Investments 0 0 0 0 1 18 10 6 2 4 3 3 4
97 70 63 57 89 118 137 163 154 140 152 102 112
Total Assets 232 190 171 122 155 208 223 241 228 222 228 197 208

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
60 28 7 -4 -4 14 -11 10 12 -9 23 -9
-22 3 1 1 -3 -27 -7 -11 -2 -5 10 -22
-39 -29 -10 4 10 14 13 0 10 -2 -1 2
Net Cash Flow -2 2 -1 2 3 0 -5 -0 20 -16 32 -28

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 220 188 167 25 48 111 158 252 213 77 80 66
Inventory Days 132 122 94 53 95 65 60 30 97 114 128 177
Days Payable 407 95 106 67 123 153 134 177 128 130 197 197
Cash Conversion Cycle -55 215 156 12 19 23 85 105 182 61 11 46
Working Capital Days 29 -368 84 59 56 122 187 202 277 222 43 72
ROCE % 1% -10% -12% -3% 5% 8% -0% 4% 1% 1% -2% -2%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
41.77% 42.23% 42.23% 42.23% 42.23% 42.23% 42.23% 37.73% 37.73% 37.73% 37.73% 34.56%
0.04% 0.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.29% 0.15% 1.69%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.16% 6.21% 6.05% 0.00%
58.20% 57.59% 57.77% 57.77% 57.78% 57.78% 57.78% 62.25% 53.10% 53.75% 56.05% 63.76%
No. of Shareholders 25,15524,75424,31724,30524,30823,96523,80022,79422,64826,44825,76825,994

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls